|
HERPUD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.006100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.359590E-01 |
| Normal-vs-Stage2 |
1.049800E-01 |
| Normal-vs-Stage3 |
4.038000E-01 |
| Normal-vs-Stage4 |
1.985000E-01 |
| Stage1-vs-Stage2 |
4.529000E-01 |
| Stage1-vs-Stage3 |
8.663000E-01 |
| Stage1-vs-Stage4 |
8.882800E-01 |
| Stage2-vs-Stage3 |
3.691000E-01 |
| Stage2-vs-Stage4 |
5.996000E-01 |
| Stage3-vs-Stage4 |
8.150200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.537900E-02 |
| Normal-vs-AfricanAmerican |
1.193410E-01 |
| Normal-vs-Asian |
5.947800E-01 |
| Caucasian-vs-AfricanAmerican |
9.614200E-01 |
| Caucasian-vs-Asian |
8.817000E-01 |
| AfricanAmerican-vs-Asian |
8.892800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.027600E-02 |
| Normal-vs-Female |
1.313510E-02 |
| Male-vs-Female |
2.420400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.171200E-01 |
| Normal-vs-Extreme_Weight |
2.954400E-01 |
| Normal-vs-Obese |
3.946000E-02 |
| Normal-vs-Extreme_Obese |
9.570200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.344800E-01 |
| Normal_Weight-vs-Obese |
2.765200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.663200E-01 |
| Extreme_Weight-vs-Obese |
4.422200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.384600E-01 |
| Obese-vs-Extreme_Obese |
3.235200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.49960000000038E-05 |
| Normal-vs-Age(41-60Yrs) |
2.261300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.860800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.589400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.660100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.125800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.145700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.359400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.308400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.232500E-04 |
| Normal-VS-Type2 PRCC |
3.579400E-01 |
| Normal-VS-KIRP CIMP |
4.742400E-02 |
| Normal-VS-Unclassified PRCC |
1.366170E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.596820E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.600600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.884800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.134300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.105600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.360000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.773800E-01 |
| Normal-vs-N1 |
4.541900E-02 |
| Normal-vs-N2 |
9.703800E-01 |
| N0-vs-N1 |
1.812310E-02 |
| N0-vs-N2 |
8.297200E-01 |
| N1-vs-N2 |
3.700600E-01 |
|
|
